| Not Yet Recruiting | A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events NCT07474649 | Daiichi Sankyo | Phase 3 |
| Not Yet Recruiting | Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD NCT07524101 | Yonsei University | N/A |
| Not Yet Recruiting | Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome NCT07508254 | Punjab Institute of Cardology | Phase 4 |
| Not Yet Recruiting | A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hyperchol NCT07477704 | Regeneron Pharmaceuticals | Phase 2 |
| Recruiting | Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile NCT07514663 | Midwest Center for Metabolic and Cardiovascular Research | N/A |
| Not Yet Recruiting | Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial NCT07382414 | Tor Biering-Sørensen | N/A |
| Not Yet Recruiting | A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PC NCT07404553 | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 2 / Phase 3 |
| Not Yet Recruiting | Vascular Intervention Strategies Trial for Alzheimer's NCT07447206 | University of Southern California | Phase 2 |
| Recruiting | WB-EMS Effects on Cardiometabolic Risk Factors NCT07406191 | University of Erlangen-Nürnberg Medical School | N/A |
| Not Yet Recruiting | Activate Tennessee: A CHW-Supported Program for Patient Activation NCT07279415 | Meharry Medical College | N/A |
| Recruiting | Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in NCT07374861 | Federico II University | — |
| Enrolling By Invitation | Improving Lipid Optimization Quality and Treatment Options in ASCVD NCT06960655 | Brigham and Women's Hospital | N/A |
| Recruiting | Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia NCT07295327 | Fondazione IRCCS Policlinico San Matteo di Pavia | N/A |
| Active Not Recruiting | Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels NCT07026266 | Società Generale delle Acque Minerali S.p.A. | N/A |
| Completed | Dachundou No Sugar Added Soymilk for Lipid Modulation NCT07175766 | National Taiwan Sport University | N/A |
| Withdrawn | Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency NCT05393882 | Chinese University of Hong Kong | — |
| Recruiting | A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe NCT07083206 | Ahn-Gook Pharmaceuticals Co.,Ltd | — |
| Completed | Pharmacokinetics of Butyrate Tablet BKR-017 NCT06556745 | BioKier Inc. | — |
| Not Yet Recruiting | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R NCT06717360 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 3 |
| Recruiting | Pharmacogenomic Informed Statin Prescribing NCT06568601 | VA Office of Research and Development | N/A |
| Completed | To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults NCT06931327 | AJU Pharm Co., Ltd. | Phase 1 |
| Recruiting | Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels NCT05988866 | Gaia AG | N/A |
| Completed | A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Ad NCT07409636 | Novartis Pharmaceuticals | — |
| Not Yet Recruiting | RCT for the Chinese Medicine in Treating Hypercholesterolemia NCT06700408 | Chinese University of Hong Kong | Phase 2 |
| Not Yet Recruiting | In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme NCT06675994 | LifeBridge Health | — |
| Recruiting | A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471 | Hasten Biopharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia NCT06451770 | Verve Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. NCT06423365 | University of Utah | N/A |
| Enrolling By Invitation | A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants NCT06504043 | Hasten Biopharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Extra Virgin Olive Oil Supplementation in Pregnancies With Increased Cholesterol Levels NCT06567951 | Universidad de los Andes, Chile | N/A |
| Enrolling By Invitation | Functional Cereal Products and Contribution to the Regulation of Metabolism and Obesity-induced Chronic Low-gr NCT06822621 | Harokopio University | N/A |
| Active Not Recruiting | Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hy NCT06492291 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial NCT06488105 | Wake Forest University Health Sciences | Phase 2 |
| Completed | A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetim NCT06450366 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With At NCT06431763 | Novartis Pharmaceuticals | Phase 4 |
| Enrolling By Invitation | Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Dise NCT06112327 | Verve Therapeutics, Inc. | — |
| Recruiting | PMMHRI-Pitavastatin Registry NCT06858982 | Polish Mother Memorial Hospital Research Institute | — |
| Recruiting | Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol) NCT06481020 | University of Valencia | N/A |
| Not Yet Recruiting | Effect of a Dietary Supplement on Lipid Pattern, Indexes of NAFLD and Systemic Inflammation in Healthy Subject NCT06403748 | University of Bologna | N/A |
| Not Yet Recruiting | Middle Term Effect of Red Yeast Rice on Plasma Lipids and Proteoma in Individuals With Suboptimal Cholesterole NCT06368258 | University of Bologna | N/A |
| Completed | A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Pa NCT06595069 | Novartis | — |
| Not Yet Recruiting | Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk NCT06355544 | Integrative Phenomics | — |
| Active Not Recruiting | Elevated Lipoprotein(a) in Hospital Staff NCT06304415 | Changi General Hospital | — |
| Completed | How Cricket Powder Affects Gut Microbiome and Cholesterol Metabolism NCT07009756 | Mahidol University | N/A |
| Recruiting | Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Wom NCT06220266 | Dhurakij Pundit University | Phase 2 / Phase 3 |
| Completed | Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies NCT06005597 | NewAmsterdam Pharma | Phase 3 |
| Completed | Red Yeast Rice for Primary Prevention of Hypercholesterolemia NCT06301906 | Chang Gung Memorial Hospital | — |
| Completed | Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality NCT06334042 | Oguzhan Kahveci | — |
| Completed | Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescription NCT06448234 | S.LAB (SOLOWAYS) | N/A |
| Unknown | Argentine Registry of Lp(a) NCT06297239 | School of Medicine. National University of Cuyo | — |
| Not Yet Recruiting | The Impact of Using a Smartphone Health Application in the Improvement of Cardiovascular Disease Risk Factors NCT05798442 | Sultan Qaboos University | N/A |
| Completed | Anti-eryptotic Effect of a Food Supplement with Plants Sterols in Hypercholesterolemia Treated with Statins NCT05901246 | University of Valencia | N/A |
| Active Not Recruiting | Effect of the Food Supplement TOTUM-070 on Lipid Metabolism NCT06243484 | Valbiotis | N/A |
| Recruiting | Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health NCT06065098 | Tulane University | N/A |
| Active Not Recruiting | Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elev NCT07442630 | JW Pharmaceutical | Phase 4 |
| Completed | A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-01 NCT05952856 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hyperchole NCT05952869 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Effect of Sunflower Seed Consumption on Blood Cholesterol Levels in Adults NCT07231367 | University of Faisalabad | N/A |
| Completed | A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intoler NCT05923281 | Kowa Company, Ltd. | Phase 3 |
| Unknown | Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Ester NCT05836909 | Lili Yang | N/A |
| Completed | Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） NCT05795517 | Haisco Pharmaceutical Group Co., Ltd. | Phase 2 |
| Recruiting | PET Imaging of Inflammation and Lipid Lowering Study NCT04073797 | University of Cambridge | N/A |
| Active Not Recruiting | Evaluation of Green Tea for Improving Blood Lipid Profile NCT06992765 | Taipei Medical University | N/A |
| Completed | Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving L NCT05763875 | Novartis Pharmaceuticals | Phase 3 |
| Unknown | A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered NCT05762276 | Vaxxinity, Inc. | Phase 1 |
| Completed | Clinical Trials of Effects of Time Restricted Eating on Health Parameters in Adults NCT05730231 | University of Primorska | N/A |
| Completed | Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selec NCT05988099 | AronPharma Sp. z o. o. | N/A |
| Unknown | Effect of Silibinin(A) as a Potential Anti-obesity Agent NCT05069298 | Universidad Católica San Antonio de Murcia | N/A |
| Completed | A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once NCT05694260 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | Peripheral Treg Cell Senescence & Serum Total Cholesterol Level NCT05680844 | Tianjin Medical University | — |
| Terminated | Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio- NCT05594979 | Valbiotis | N/A |
| Recruiting | Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Ita NCT06287177 | Federico II University | — |
| Completed | A Study of MK-0616 in Healthy Adult Participants (MK-0616-009) NCT06592339 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes NCT07382778 | JW Pharmaceutical | — |
| Completed | A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in NCT06507852 | Novartis | — |
| Unknown | Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment NCT05457439 | University of Guadalajara | N/A |
| Completed | A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012) NCT06655311 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | Ezetimibe-Rosuvastatin Evaluation Study NCT03947866 | Elpen Pharmaceutical Co. Inc. | — |
| Recruiting | Guideline Oriented Approach To Lipid Lowering In Asia-Pacific NCT05325034 | Stephen Nicholls | N/A |
| Completed | Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05425745 | NewAmsterdam Pharma | Phase 3 |
| Unknown | Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease NCT05459519 | China National Center for Cardiovascular Diseases | N/A |
| Completed | A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease NCT05398029 | Verve Therapeutics, Inc. | Phase 1 |
| Completed | Effects of Chios Mastiha Essential Oil on Cholesterol Levels of Healthy Volunteers NCT05858372 | AHEPA University Hospital | N/A |
| Completed | A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin NCT05421078 | NewAmsterdam Pharma | Phase 2 |
| Completed | Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients NCT05004675 | LIB Therapeutics LLC | Phase 3 |
| Completed | Screening for Hypercholesterolemia in Children Using Dried Blood Spot NCT05191355 | Hospices Civils de Lyon | — |
| Completed | The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential NCT06435130 | Medical University of Bialystok | N/A |
| Completed | SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to NCT05546398 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Completed | Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults NCT05333315 | University of Primorska | N/A |
| Completed | Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoi NCT05192941 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fa NCT06247137 | University of Bologna | N/A |
| Completed | A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hyperch NCT05261126 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy NCT05266586 | NewAmsterdam Pharma | Phase 2 |
| Completed | Effects of a Chilean Diet Supplemented With Gevuina Avellana on Lipid Profile in Humans With Hypercholesterole NCT07087704 | Universidad de Concepcion | N/A |
| Unknown | Metabolic Effect of an Innovative Chitosan Formulation NCT05188430 | University of Bologna | N/A |
| Completed | Independent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterol NCT05267522 | University of South Australia | N/A |
| Completed | A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowe NCT05362903 | Novartis Pharmaceuticals | — |
| Completed | Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug P NCT05234775 | LIB Therapeutics LLC | Phase 3 |
| Completed | Investigating the Dose Response of an Almond-enriched Diet on Optimizing HDL-C in a Population With Hyperchole NCT05174663 | Almond Board of California | N/A |
| Completed | Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Str NCT05574049 | Medical Life Care Planners, LLC | EARLY_Phase 1 |
| Completed | Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimib NCT07445542 | JW Pharmaceutical | — |
| Completed | Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05142722 | NewAmsterdam Pharma | Phase 3 |
| Completed | Effect of Oleactiv® on LDL Oxidability NCT05221346 | Institut Pasteur de Lille | N/A |
| Completed | The Effect of Progressive Resistance Exercise Training (PRET) on CVRF in Adults With ID. NCT06579898 | Erasmus Medical Center | N/A |
| Completed | Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia NCT04573218 | Isa Naina Mohamed | Phase 2 |
| Completed | Diet-induced Elevations in LDL-C and Progression of Atherosclerosis NCT05733325 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | — |
| Completed | Diet and Plant Sterols in the Control of Cholesterolemia (DESCO) NCT05265455 | University of Bologna | N/A |
| Recruiting | Role of A2A Receptor in Hypercholesterolemic Patients NCT05017649 | Assistance Publique Hopitaux De Marseille | N/A |
| Enrolling By Invitation | Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia NCT04929457 | Karolinska Institutet | — |
| Unknown | Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product NCT05126056 | Raisio Group | N/A |
| Completed | A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, NCT07489183 | Dong Wha Pharmaceutical Co. Ltd. | — |
| Completed | Lipid Lowering Effect of Plant Stanol Ester in a Spoonable Non-dairy Product NCT05064644 | Raisio Group | N/A |
| Suspended | Baromètre Santé Adulte 2021-2022 NCT05218304 | Agence Sanitaire et Sociale de Nouvelle Calédonie | N/A |
| Active Not Recruiting | Onco-primary Care Networking to Support TEAM-based Care NCT04258813 | Duke University | N/A |
| Completed | Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation NCT04974853 | NMP Medical Research Institute | N/A |
| Unknown | Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmaph NCT04897113 | National Medical Research Center for Rehabilitation and Balneology | N/A |
| Completed | Clinical Trials of Two Helichrysum Infusions in Adults NCT04866628 | University of Primorska | N/A |
| Completed | Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults NCT04783714 | Swisse Wellness Pty Ltd | N/A |
| Completed | Supplements, Placebo, or Rosuvastatin Study NCT04846231 | The Cleveland Clinic | Phase 2 |
| Completed | Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients NCT04790513 | LIB Therapeutics LLC | Phase 3 |
| Unknown | Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Re NCT04806893 | LIB Therapeutics LLC | Phase 3 |
| Completed | Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolem NCT04927221 | Guangzhou JOYO Pharma Co., Ltd | Phase 1 |
| Completed | A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia NCT04784442 | Otsuka Pharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease ( NCT04765657 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Randomized Study of Obicetrapib in Combination With Ezetimibe NCT04770389 | NewAmsterdam Pharma | Phase 2 |
| Completed | Randomized Study of Obicetrapib as an Adjunct to Statin Therapy NCT04753606 | NewAmsterdam Pharma | Phase 2 |
| Completed | Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects NCT04760951 | Valbiotis | N/A |
| Completed | A Study of IBI306 in Participants With Hypercholesterolemia NCT04709536 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 3 |
| Completed | Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated NCT04666298 | Novartis Pharmaceuticals | Phase 2 |
| Active Not Recruiting | Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia NCT04579367 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Completed | PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health NCT04673721 | Duke University | N/A |
| Completed | Hypocholesterolemic Effect of a Phytosterol-enriched Spreadable Cream Prepared With Virgin Olive Oil NCT05460208 | Universidad de Granada | N/A |
| Unknown | German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germa NCT05438069 | Jena University Hospital | — |
| Completed | Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nut NCT05000541 | Mylan Inc. | — |
| Completed | A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chi NCT04669041 | Sanofi | Phase 3 |
| Unknown | Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia NCT04659525 | Policlinico Casilino ASL RMB | Phase 4 |
| Completed | Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia NCT04485793 | University of Bologna | N/A |
| Completed | Food Supplementation With Eufortyn Colesterolo Plus for LDL Modulation in Subjects With Polygenic Hypercholest NCT04574505 | University of Bologna | N/A |
| Unknown | Nutritional Intervention With Black Garlic NCT05082350 | Maria Pilar Zafrilla Rentero | N/A |
| Terminated | Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion NCT04314167 | University Hospital Tuebingen | N/A |
| Completed | Kefir Cholesterol Lowering Pilot Study NCT04247139 | University of Alberta | N/A |
| Completed | Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety NCT06293261 | Yuhan Corporation | — |
| Completed | Effects of Atorvastatin in Graves' Orbitopathy (GO) NCT03110848 | University of Pisa | Phase 2 |
| Completed | A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia NCT04358432 | Akeso | Phase 2 |
| Unknown | Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients NCT04397653 | Policlinico Casilino ASL RMB | Phase 4 |
| Completed | HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities NCT03206164 | University of Illinois at Chicago | N/A |
| Completed | Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia NCT04289285 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 3 |
| Unknown | Effect of Atorvastatin on Carotid Intima Media Thickness NCT04306627 | Yerevan State Medical University | Phase 4 |
| Completed | K-924 Phase III Confirmatory Study NCT04289649 | Kowa Company, Ltd. | Phase 3 |
| Completed | K-924 Phase III Long Term Study NCT04289662 | Kowa Company, Ltd. | Phase 3 |
| Completed | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events NCT04271280 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Recruiting | Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy NCT05430828 | Federico II University | — |
| Completed | Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors NCT04319081 | Jose Seijas Amigo | — |
| Unknown | Plant Sterol INtervention for Cancer Prevention (PINC) NCT04147767 | University of Leeds | N/A |
| Completed | The Efficacy of Cholesterol-lowering Probiotic Lactobacillus Plantarum LPLDL® in Hypercholesterolemic Adults. NCT03540108 | University of Roehampton | N/A |
| Completed | Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine NCT04158076 | Addpharma Inc. | Phase 3 |
| Unknown | Supplementation of Oil Palm Phenolics to Healthy Participants NCT04164446 | National University of Malaysia | Phase 1 |
| Active Not Recruiting | Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study NCT04536870 | Monash University | N/A |
| Completed | Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy NCT04164888 | Civi Biopharma, Inc. | Phase 2 |
| Completed | A Long-term Study of AK102 in Patients With Hypercholesterolemia NCT04173403 | Akeso | Phase 2 |
| Completed | Evaluating the Efficacy of Pediatric Lipid Screening Alerts NCT04118348 | Geisinger Clinic | N/A |
| Completed | Health Effects of Consuming Olive Pomace Oil NCT04998695 | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | N/A |
| Completed | Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C- NCT03768427 | Organon and Co | Phase 3 |
| Completed | Effect of Pitavastatin on Bone NCT06359353 | Seoul National University Bundang Hospital | Phase 4 |
| Completed | Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary NCT03718286 | Population Health Research Institute | Phase 2 |
| Completed | Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia NCT03815812 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 2 |
| Completed | Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol an NCT03830970 | University of Guelph | N/A |
| Completed | Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan NCT03872232 | Addpharma Inc. | Phase 3 |
| Completed | Artichoke and Bergamot Phytosome NCT04697121 | Azienda di Servizi alla Persona di Pavia | N/A |
| Completed | Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 NCT03847974 | LIB Therapeutics LLC | Phase 2 |
| Completed | CoQ10 in Statin-associated Asthenia NCT06391606 | University of Bologna | N/A |
| Completed | Translation of Pritikin Program to the Community NCT03929198 | Washington University School of Medicine | N/A |
| Unknown | The Effect of Viscous Dietary Fibers on LDL-cholesterol NCT04133805 | Unity Health Toronto | — |
| Completed | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholester NCT03510715 | Sanofi | Phase 3 |
| Completed | Diets Enriched With Pecans NCT04376632 | University of Georgia | N/A |
| Completed | Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients NCT03611010 | Cumberland Pharmaceuticals | Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male S NCT03593785 | AstraZeneca | Phase 1 |
| Completed | Safety and Efficacy of Propionate for Reduction of LDL Cholesterol NCT03590496 | Charite University, Berlin, Germany | N/A |
| Completed | Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body Composition NCT03587051 | University of Saskatchewan | N/A |
| Unknown | The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment NCT04270344 | JW Pharmaceutical | — |
| Terminated | Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Ar NCT03559309 | Medical University of Graz | Phase 4 |
| Unknown | Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population NCT03543774 | Hue University of Medicine and Pharmacy | Phase 4 |
| Unknown | Effect of Indian Gooseberry Extract (AMX160) in Hypercholesterolemia NCT03479983 | Arjuna Natural Limited | N/A |
| Completed | Oil Consumption and Cholesterol NCT04397055 | University of Georgia | N/A |
| Unknown | Alirocumab in Patients on a Stable Dialysis Regimen NCT03480568 | Baylor Research Institute | Phase 3 |
| Completed | A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia NCT03381287 | HighTide Biopharma Pty Ltd | Phase 1 / Phase 2 |
| Completed | Health Effects of Consuming Olive Pomace Oil NCT04997122 | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | N/A |
| Unknown | Detection and Treatment of Somatic Disease in Patients With Severe Mental Disease NCT03428308 | Intersectoral Research Unit for Health Services | N/A |
| Completed | Interplay Between Adherence to the Mediterranean Diet, Lipid Profile and Blood Pressure: a Comparative Survey NCT04596358 | University of Bari Aldo Moro | — |
| Completed | Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolem NCT03446261 | Yuhan Corporation | Phase 4 |
| Completed | A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level NCT03427710 | Civi Biopharma, Inc. | Phase 1 |
| Completed | The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions NCT03631238 | Assiut University | — |
| Terminated | Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study NCT03379558 | Regeneron Pharmaceuticals | — |
| Completed | A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health Subjects NCT04197817 | Shanghai Junshi Bioscience Co., Ltd. | Phase 1 |
| Completed | Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects. NCT03366688 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
| Completed | Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia NCT03175367 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 NCT03545438 | LIB Therapeutics LLC | Phase 1 |
| Completed | Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels NCT03739242 | A. Menarini Industrie Farmaceutiche Riunite S.r.l. | N/A |
| Completed | Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg NCT04511000 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Unknown | The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management Study NCT03428061 | UMC Utrecht | — |
| Completed | Lipid-lowering Therapy Individualization NCT03604471 | Université Catholique de Louvain | Phase 4 |
| Completed | Nutraceutical in Cardiovascular Primary Prevention NCT03216811 | University Hospital of Ferrara | Phase 2 |
| Completed | Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease NCT03161327 | St. Louis University | N/A |
| Terminated | Genetic Basis for Prediction of Non-responders to Dietary Plant Sterol Intervention NCT02765516 | University of Manitoba | N/A |
| Completed | Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia NCT03550287 | Instituto de Investigación Hospital Universitario La Paz | Phase 4 |
| Terminated | Anti-inflammatory Effects of Simvastatin NCT04638400 | paresh Dandona | Phase 4 |
| Completed | Phytosterol Supplementation and Lipoprotein Subfractions NCT06127732 | Federal University of São Paulo | N/A |
| Completed | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy NCT03193047 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia NCT03429998 | Hospital General Universitario Gregorio Marañon | Phase 3 |
| Completed | Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) NCT03067441 | Esperion Therapeutics, Inc. | Phase 3 |
| Withdrawn | Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 NCT02955368 | Alvogen Korea | Phase 3 |
| Completed | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 NCT03051100 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients NCT03470376 | University Of Perugia | Phase 4 |
| Completed | A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles NCT03172611 | Texas Woman's University | N/A |
| Completed | Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertrigly NCT02989753 | Valbiotis | Phase 1 / Phase 2 |
| Completed | Alirocumab in Patients With Acute Myocardial Infarction NCT02938949 | Virginia Commonwealth University | Phase 4 |
| Unknown | Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal M NCT03469518 | Puerta de Hierro University Hospital | N/A |
| Completed | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alir NCT02979015 | Sanofi | Phase 1 |
| Completed | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients NCT03001076 | Esperion Therapeutics, Inc. | Phase 3 |
| Completed | The Combined Portfolio Diet and Exercise Study NCT02481466 | Unity Health Toronto | N/A |
| Completed | Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiova NCT02991118 | Esperion Therapeutics, Inc. | Phase 3 |
| Completed | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin NCT02988115 | Esperion Therapeutics, Inc. | Phase 3 |
| Completed | Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function NCT03065491 | University of Bologna | N/A |
| Completed | Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Cor NCT02984982 | Sanofi | Phase 4 |
| Completed | Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo NCT02957682 | Regeneron Pharmaceuticals | Phase 4 |
| Completed | Effects of Nutraceutical Therapies on Endothelial Function, Platelet Aggregation, and Coronary Flow Reserve NCT02969070 | Federico II University | N/A |
| Completed | Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With H NCT02715726 | Sanofi | Phase 3 |
| Completed | LDL-cholesterol Lowering Effect of a New Dietary Supplement NCT03425630 | Ispharm srl | N/A |
| Completed | Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan NCT02808403 | Amgen | — |
| Completed | A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-83 NCT02741245 | Organon and Co | Phase 3 |
| Completed | Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their NCT02857543 | The Cleveland Clinic | N/A |
| Completed | Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults NCT02911753 | University of Arizona | N/A |
| Terminated | Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Inte NCT02818283 | Ohio State University | N/A |
| Completed | A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hyp NCT02748057 | Organon and Co | Phase 3 |
| Completed | Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia NCT02739984 | Amgen | Phase 3 |
| Completed | Nutraceuticals and Vascular Remodelling NCT04433429 | Marcello Rattazzi | — |
| Completed | Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) NCT03074630 | Amsterdam UMC, location VUmc | Phase 4 |
| Completed | A Study to Evaluate the Effects of Dietary Fiber on Blood Lipids in Men and Women NCT02835872 | Tate & Lyle | N/A |
| Completed | The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids NCT02728583 | Unilever R&D | N/A |
| Completed | A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Ver NCT02749994 | IlDong Pharmaceutical Co Ltd | Phase 3 |
| Completed | Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia NCT02689934 | Montefarmaco OTC SpA | N/A |
| Completed | Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients NCT05467384 | Ayub Teaching Hospital | Phase 4 |
| Completed | Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects NCT02681055 | MediciNova | Phase 2 |
| Active Not Recruiting | Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy NCT02694094 | Johns Hopkins University | — |
| Completed | Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults NCT02734706 | UAS Labs LLC | N/A |
| Completed | Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe NCT02772640 | Collegium Medicum w Bydgoszczy | Phase 4 |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 NCT02634580 | Amgen | Phase 3 |
| Terminated | Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyalur NCT02667223 | Pfizer | Phase 1 |
| Completed | Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High NCT02666664 | Esperion Therapeutics, Inc. | Phase 3 |
| Completed | The Cholesterol Lowering Effects of Strawberry NCT02612090 | Clinical Nutrition Research Center, Illinois Institute of Technology | N/A |
| Completed | Graves' Orbitopathy and Hypercholesterolemia NCT02721992 | University of Pisa | — |
| Completed | Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester NCT03284918 | Raisio Group | N/A |
| Completed | Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment NCT02585895 | Amgen | Phase 3 |
| Completed | Sí Texas Hope Family Health Center NCT03916016 | Health Resources in Action, Inc. | N/A |
| Unknown | EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA NCT02657759 | Direct Plantes | N/A |
| Completed | Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-sta NCT02584504 | Sanofi | Phase 3 |
| Completed | Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexic NCT03881657 | Health Resources in Action, Inc. | N/A |
| Terminated | Single Dose Study of PF-06815345 in Healthy Subjects NCT02654899 | Pfizer | Phase 1 |
| Completed | Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Stud NCT02579655 | University of Calgary | N/A |
| Completed | Measuring the Impact of Dietary Supplementation With a New Baking Product on Gut Microbiota and Cholesterol Me NCT02664428 | Fondazione Edmund Mach | N/A |
| Completed | Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Pat NCT03949374 | Yonsei University | Phase 4 |
| Completed | A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hyperc NCT02608697 | Catabasis Pharmaceuticals | Phase 2 |
| Completed | Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols NCT02644109 | University of Chile | Phase 4 |
| Completed | A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterole NCT02550288 | Organon and Co | Phase 3 |
| Completed | Validating the "Foods for Health" Portfolio of Functional Food Products NCT02341924 | University of Manitoba | N/A |
| Completed | Electronic Medical Records and Genomics (eMERGE) Phase III NCT03394859 | Vanderbilt University Medical Center | — |
| Completed | Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in H NCT02508896 | Affiris AG | Phase 1 |
| Completed | Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholester NCT02476006 | Sanofi | Phase 3 |
| Completed | A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hyp NCT02460159 | Organon and Co | Phase 3 |
| Completed | Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS) NCT02693782 | University of Aberdeen | N/A |
| Completed | Nattokinase Supplementation and Hemostatic Factors NCT02913170 | Yonsei University | Phase 4 |
| Completed | Patient and Provider Assessment of Lipid Management Registry NCT02341664 | Duke University | — |
| Completed | Hypocholesterolemic Effect of Fibracep NCT04545463 | Universitat de Lleida | N/A |
| Completed | Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes NCT02827630 | Proteus Digital Health, Inc. | N/A |
| Completed | Atorvastatin Study in Cardiovascular Disease Risk NCT02392416 | Elpen Pharmaceutical Co. Inc. | — |
| Completed | Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination NCT02603276 | University of Bologna | N/A |
| Terminated | Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients NCT02499185 | Universitair Ziekenhuis Brussel | Phase 4 |
| Completed | Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factor NCT02317003 | University Hospital, Angers | N/A |
| Completed | Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects NCT02609295 | Yonsei University | Phase 3 |
| Completed | Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and NCT02289963 | Sanofi | Phase 3 |
| Completed | A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharma NCT02374047 | Catabasis Pharmaceuticals | Phase 1 |
| Terminated | A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hype NCT02260648 | Eli Lilly and Company | Phase 3 |
| Completed | Postprandial Lipemia and Glycemia Following a High-Fat Meal NCT05619952 | State University of New York at Buffalo | N/A |
| Completed | A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Chole NCT02314442 | Alnylam Pharmaceuticals | Phase 1 |
| Completed | Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab NCT02304484 | Amgen | Phase 3 |
| Completed | Retinoic Acid Supplementation and Subjects With Hypercholesterolemia NCT02497833 | Sun Yat-sen University | EARLY_Phase 1 |
| Completed | Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia NCT02390375 | Daewon Pharmaceutical Co., Ltd. | Phase 3 |
| Terminated | A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia NCT02260635 | Eli Lilly and Company | Phase 3 |
| Completed | Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin NCT04921657 | Chinese University of Hong Kong | — |
| Completed | The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in P NCT03288038 | Shin Poong Pharmaceutical Co. Ltd. | Phase 3 |
| Completed | Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol NCT04677335 | AB Biotics, SA | N/A |
| Completed | The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Me NCT02288585 | Unilever R&D | N/A |
| Unknown | Vascular Lifestyle-Intervention and Screening in Pharmacy NCT02223793 | University of Oslo | N/A |
| Unknown | The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvasta NCT02251847 | IlDong Pharmaceutical Co Ltd | Phase 3 |
| Completed | Nutraceutical Combination in Patients With Low-grade Systemic Inflammation NCT02422927 | University Of Perugia | Phase 4 |
| Completed | The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human NCT02475018 | Inner Mongolia Yili Industrial Group Co., Ltd | N/A |
| Completed | Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension NCT02178098 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | Short Term Intermittent Fasting and Mediterranean Diet NCT02148458 | Washington University School of Medicine | N/A |
| Completed | Lipid-lowering Effect of a Plant Stanol Ester Supplement Product NCT02221297 | Raisio Group | N/A |
| Completed | Replacement of Saturated Fat in Dairy on Total Cholesterol NCT02089035 | University of Reading | N/A |